Scott Rocklage is a Managing Partner at 5AM Ventures, a capital firm that supports its clients in the start-up and early stages of their business. Its clients are mostly in the science, medical and biopharmaceutical fields. Scott has more than 30 years in the healthcare field.
With his remarkable management skills, he led the successful approval of 3 vital New Drug Applications by the FDA. These are Omniscan, Cubicin and Teslascan. Additionally, he has seen six drug candidates go to clinical trials. Scott has an impressive scientific background and strategic leadership skills.
Dr. Scott Rocklage holds a Ph.D. in Chemistry from the Massachusetts Institute of Technology (MIT) and a Bachelors degree in Chemistry from the University of California. In 1989, Dr. Rocklage joined Nycomed Salutar, a diagnostic imaging firm where he served as the CEO and President. Read more: Scott Racklage | Crunchbase
In 1994, he moved to Cubist Pharmaceuticals where he was the chairman and CEO. In 2003, Scott joined 5AM Ventures as a Venture Partner and was promoted to Managing Partner in 2004. Dr. Rocklage has served as CEO and president in other firms such as Nycomed Interventional, Amersham Health, EPIRUS Biopharmaceuticals and Ilypsa. He also worked as a director in other organizations such as Protana and Achaegon.
Scott is the Chairman of the Board of Cidara, Kinestral, and Rennovia and also serves on the Board of other firms such as Relypsa, Pulmatrix and Epirus. Dr. Rocklage is also a renowned author and has made over 100 peer-reviewed publications. With his creative skills, he has invented more than thirty U.S. patents.
Scott Rocklage is a celebrated philanthropist. Together with his wife, Patty Rocklage, they donated $0.25 Million to aid in the renovation of MIT’s nano chemistry and nanotechnology labs. Scott stated that this was an appreciation to the institution for laying a firm foundation for his career and professional life.
MIT put up a plaque as a way of honoring Scott and his wife. Rocklage is also a Board member at Whitehead Institute, a non-profit organization that specializes in educational and biomedical research.
Scott Rocklage is indisputably a brilliant manager and leader with an outstanding academic background. He continues to make a great impact in the healthcare and science industry.